Original Papers- YAMAMOTO Masayuki -
number of results to view: what to display: sort:
total:803
[2003]
601.Hematological aspects of a novel 9-aminoanthracycline, amrubicin..[Cancer Sci,94(12),(2003),1104-1106]Obara Naoshi, Imagawa Shigehiko, Nakano Yoko, Yamamoto Masayuki, Noguchi Toshihiro, Nagasawa Toshiro
602.Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway..[Mol Cell Biol,23(23),(2003),8786-8794]Kwak Mi-Kyoung, Wakabayashi Nobunao, Greenlaw Jennifer L, Yamamoto Masayuki, Kensler Thomas W
603.Nrf2 regulates the sensitivity of death receptor signals by affecting intracellular glutathione levels..[Oncogene,22(58),(2003),9275-9281]Morito Naoki, Yoh Keigyou, Itoh Ken, Hirayama Aki, Koyama Akio, Yamamoto Masayuki, Takahashi Satoru
604.Self-association of Gata1 enhances transcriptional activity in vivo in zebra fish embryos..[Mol Cell Biol,23(22),(2003),8295-8305]Nishikawa Keizo, Kobayashi Makoto, Masumi Atsuko, Lyons Susan E, Weinstein Brant M, Liu P Paul, Yamamoto Masayuki
605.Expression of the aflatoxin B1-8,9-epoxide-metabolizing murine glutathione S-transferase A3 subunit is regulated by the Nrf2 transcription factor through an antioxidant response element..[Mol Pharmacol,64(5),(2003),1018-1028]Jowsey Ian R, Jiang Qing, Itoh Ken, Yamamoto Masayuki, Hayes John D
606.Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation..[Nat Genet,35(3),(2003),238-245]Wakabayashi Nobunao, Itoh Ken, Wakabayashi Junko, Motohashi Hozumi, Noda Shuhei, Takahashi Satoru, Imakado Sumihisa, Kotsuji Tomoe, Otsuka Fujio, Roop Dennis R, Harada Takanori, Engel James Douglas, Yamamoto Masayuki
607.Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels..[Blood,102(10),(2003),3575-3583]Suzuki Norio, Suwabe Naruyoshi, Ohneda Osamu, Obara Naoshi, Imagawa Shigehiko, Pan Xiaoqing, Motohashi Hozumi, Yamamoto Masayuki
608.Transgenic overexpression of GATA-3 in T lymphocytes improves autoimmune glomerulonephritis in mice with a BXSB/MpJ-Yaa genetic background..[J Am Soc Nephrol,14(10),(2003),2494-2502]Yoh Keigyou, Shibuya Kazuko, Morito Naoki, Nakano Takako, Ishizaki Kazusa, Shimohata Homare, Nose Masato, Izui Shozo, Shibuya Akira, Koyama Akio, Engel James Douglas, Yamamoto Masayuki, Takahashi Satoru
609.Toward identification of susceptibility genes for sporadic Parkinson's disease.[JOURNAL OF NEUROLOGY,250,(2003),40-43]T Toda, Y Momose, M Murata, G Tamiya, M Yamamoto, N Hattori, H Inoko
10.1007/s00415-003-1307-6
http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000186266900007&DestApp=WOS
610.Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome..[Blood,102(8),(2003),2960-2968]Xu Gang, Nagano Masumi, Kanezaki Rika, Toki Tsutomu, Hayashi Yasuhide, Taketani Takeshi, Taki Tomohiko, Mitui Tetsuo, Koike Kenichi, Kato Koji, Imaizumi Masue, Sekine Isao, Ikeda Yasuhiko, Hanada Ryoji, Sako Masahiro, Kudo Kazuko, Kojima Seiji, Ohneda Osamu, Yamamoto Masayuki, Ito Etsuro
611.Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts..[Biochem Biophys Res Commun,310(3),(2003),824-829]Hayashi Asako, Suzuki Hiroshi, Itoh Ken, Yamamoto Masayuki, Sugiyama Yuichi
612.A GATA-specific inhibitor (K-7174) rescues anemia induced by IL-1beta, TNF-alpha, or L-NMMA..[FASEB J,17(12),(2003),1742-1744]Imagawa Shigehiko, Nakano Yoko, Obara Naoshi, Suzuki Norio, Doi Takeshi, Kodama Tatsuhiko, Nagasawa Toshiro, Yamamoto Masayuki
613.Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence..[Biochem J,374(Pt 2),(2003),337-348]Nioi Paul, McMahon Michael, Itoh Ken, Yamamoto Masayuki, Hayes John D
614.化学的二量体化物質による人工的赤血球造血制御.[臨床血液,44(8),(2003),714]向井 陽美, 鈴木 教郎, 大根田 修, 長澤 俊郎, 山本 雅之
615.機能的レスキュー法を用いた個体レベルでの血球系GATA因子群の分子機能比較.[臨床血液,44(8),(2003),779]小原 直, 鈴木 教郎, 大根田 修, 高橋 智, 今川 重彦, 長澤 俊郎, 山本 雅之
616.新規GATA特異的阻害薬の経口投与による慢性貧血改善の試み.[臨床血液,44(8),(2003),714]中野 陽子, 今川 重彦, 小原 直, 鈴木 教郎, 長澤 俊郎, 山本 雅之
617.Expression and domain-specific function of GATA-2 during differentiation of the hematopoietic precursor cells in midgestation mouse embryos..[Blood,102(3),(2003),896-905]Minegishi Naoko, Suzuki Norio, Yokomizo Tomomasa, Pan Xiaoqing, Fujimoto Tetsuhiro, Takahashi Satoru, Hara Takahiko, Miyajima Atsushi, Nishikawa Shin-Ichi, Yamamoto Masayuki
618.GATA-1 testis activation region is essential for Sertoli cell-specific expression of GATA-1 gene in transgenic mouse..[Genes Cells,8(7),(2003),619-630]Wakabayashi Junko, Yomogida Kentaro, Nakajima Osamu, Yoh Keigyou, Takahashi Satoru, Engel James Douglas, Ohneda Kinuko, Yamamoto Masayuki
619.A potential mechanism for the impairment of nitric oxide formation caused by prolonged oral exposure to arsenate in rabbits..[Free Radic Biol Med,35(1),(2003),102-113]Pi Jingbo, Horiguchi Satomi, Sun Yang, Nikaido Masatoshi, Shimojo Nobuhiro, Hayashi Toshio, Yamauchi Hiroshi, Itoh Ken, Yamamoto Masayuki, Sun Guifan, Waalkes Michael P, Kumagai Yoshito
620.Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression..[J Biol Chem,278(24),(2003),21592-21600]McMahon Michael, Itoh Ken, Yamamoto Masayuki, Hayes John D
Page: [prev] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [next]
BackTop
copyright(c)2005 Tohoku University